Chromatide and Novasep extend partnership agreement

The resulting systems and equipment will meet the growing needs of biotechnology and pharmaceutical industries for more efficient, continuous flow instruments for gram to industrial scale production of high quality products.

The goal of this partnership is to combine Chromatide’s experience in solid phase synthesis of peptide and oligonucleotides, including the production of novel resins and instrumentation, to Novasep’s expertise in synthesis and purification services and technologies in the biotechnology and pharmaceutical industries to provide them with efficient solutions to obtain pure peptides and oligonucleotides.

Don Wellings, CSO of Chromatide, said: “We are delighted to be continuing to work with Novasep on this project. The extension of our collaboration is illustrative of the success we have achieved to date on developing the synthesis systems which Novasep is launching in 2008.”